CASE STUDY: LAUNCHING A NEW MEDICINE WITHOUT A FIELD FORCE (PART 1)
It was four years ago when I had a hard time combining my MBA classes and my full-time job. However, it was an enjoyable experience, and it made me love reflecting on case studies. I learnt a great deal throughout all those semi-real business challenges…
REDES SOCIALES, INDUSTRIA FARMACÉUTICA, SÍ
Llevo un tiempo trabajando en la actualización de la política de uso sobre social media en mi compañía y me vienen muchas ideas sobre lo que se puede y no se puede hacer por parte de la industria farmacéutica en las redes sociales. Porque la…
2019 SPANISH GENERAL ELECTION AND DIGITALISATION IN PHARMA: 3 LESSONS TO LEARN
Dear reader, be aware that this blog post is, once again, about digitalisation and Pharma. To my mind, there are some valuable lessons to learn from the last Spanish general election; however, I’m not by any means dissecting what happened in Spain from a political…
NO ALGORITHM, NO GAIN: ENGAGING PRESCRIBERS & DELIVERING BEST-IN-CLASS CUSTOMER EXPERIENCE
Could an algorithm improve the commercial model in Pharma? Launching a new medicine carries much effort and preparation. And yet the moment of truth comes when doctors may prescribe the product. Why is he/she picking out this new medicine instead of any other available option?…
THE PRODUCT MANAGER IS DEAD, LONG LIVE TO THE PRODUCT & CUSTOMER MANAGER!
My colleague in this blog, Javier Télez, wrote an interesting post about the role of medical sales reps. He described their job accurately and emphasised their relevance. Honestly, I can´t disagree with him but, on the other hand, I think sales teams have been covering…
VISITADOR MEDICO DEL FUTURO…VISITADOR MEDICO DEL PASADO
Ya lo he contado antes, pero llevo trabajando en la industria farmacéutica más de 18 años. Empecé de visitador médico, como una manera de estar involucrado dentro de un mundo que siempre me ha apasionado, que es el de la sanidad. Desde niño quise ser…
Why is Pharma innovating so little in terms of the go-to-market model?
Undoubtedly, the world has changed dramatically for the last 30 years. The digital revolution has brought two main consequences. The first one is the foundation of new companies providing value to consumers due to the internet: namely Google, Apple or Amazon. The second one is…
Pharma and blockchain: meaningful innovation or a lot of hype?
Arguably, the Pharma industry is one of the most innovative areas of our economy. In average, between 10-20% of companies’ turnover is ploughed back in R&D with the hope of bringing to life a blockbuster to refuel this cycle. On the other hand, if there…
Congresos y Conferencias en el sector Pharma: muchos cambios digitales pero una misma esencia
En la era en la que lo digital parece abarcarlo todo, y si en nuestro congreso o conferencia no introducimos esta palabra parece que somos unos arcaicos, resulta que la esencia principal de cualquier congreso o conferencia sigue siendo la misma que hace años. El…
Starting off
Would you dare to do XYZ? That’s the question recurrently popping into my mind. There’s always a similar pattern. Firstly, I look up to somebody doing something. Secondly, I dream about it for a while. Finally, the opportunity to start off comes up, and I…
Stay connected